Ocular complications of childhood rheumatic diseases: Uveitis

被引：7
作者：
Reiff A. [1 ]
机构：
[1] Division of Rheumatology, Mailstop 60, Childrens Hospital Los Angeles, Los Angeles, CA 90027
来源：
Current Rheumatology Reports | 2006年 / 8卷 / 6期
关键词：
Etanercept; Sarcoidosis; Juvenile Idiopathic Arthritis; Uveitis; Kawasaki Disease;
D O I：
10.1007/s11926-006-0042-2
中图分类号：
学科分类号：
摘要：
Ocular involvement is common in pediatric rheumatologic diseases, supporting the concept that these conditions cannot be understood simply as isolated entities, but rather as multisystem disorders. The reasons for the breach of the eye-brain barrier and the targeting of the usually well-shielded eye during a pan-inflammatory process remains unclear. Pediatric rheumatologists should become familiar with these ocular disorders, because as important members of the treatment team, they manage more serious cases of inflammatory eye disease. A close collaboration between the treating rheumatologist and the ophthalmologist is essential to prevent potentially devastating outcomes. Therapeutic interventions such as topical steroids, systemic immunosuppressants, and biologics must balance the necessity of controlling ocular inflammation and the adverse effects of these treatments on a growing child. Copyright © 2006 by Current Science Inc.
引用
收藏
页码：459 / 468
页数：9
相关论文
共 109 条
  • [11] Perez V.L., Papaliodis G.N., Chu D., Et al., Elevated levels of interleukin 6 in the vitreous fluid of patients with pars planitis and posterior uveitis: The Massachusetts eye & ear experience and review of previous studies, Ocul Immunol Inflamm, 12, pp. 193-201, (2004)
  • [12] Franks W.A., Limb G.A., Stanford M.R., Et al., Cytokines in human intraocular inflammation, Curr Eye Res, 11, SUPPL., pp. 187-191, (1992)
  • [13] Hooks J.J., Chan C.C., Detrick B., Identification of the lymphokines, interferon-gamma and interleukin-2, in inflammatory eye diseases, Invest Ophthalmol Vis Sci, 29, pp. 1444-1451, (1988)
  • [14] Norose K., Yano A., Wang X.C., Et al., Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease, Invest Ophthalmol Vis Sci, 35, pp. 33-39, (1994)
  • [15] Gritz D.C., Wong I.G., Incidence and prevalence of uveitis in Northern California
  • [16] the Northern California Epidemiology of Uveitis Study, Ophthalmology, 111, pp. 491-500, (2004)
  • [17] Darrell R.W., Wagener H.P., Kurland L.T., Epidemiology of uveitis. Incidence and prevalence in a small urban community, Arch Ophthalmol, 68, pp. 502-514, (1962)
  • [18] Edelsten C., Reddy M.A., Stanford M.R., Graham E.M., Visual loss associated with pediatric uveitis in english primary and referral centers, Am J Ophthalmol, 135, pp. 676-680, (2003)
  • [19] Paivonsalo-Hietanen T., Tuominen J., Saari K.M., Uveitis in children: Population-based study in Finland, Acta Ophthalmol Scand, 78, pp. 84-88, (2000)
  • [20] Cassidy J.T., Sullivan D.B., Petty R.E., Clinical patterns of chronic iridocyclitis in children with juvenile rheumatoid arthritis, Arthritis Rheum, 20, 2 SUPPL., (1977)
12345678910